Previous Close | 0.6000 |
Open | 0.6000 |
Bid | 0.0000 |
Ask | 1.1000 |
Strike | 5.00 |
Expire Date | 2025-01-17 |
Day's Range | 0.6000 - 0.6000 |
Contract Range | N/A |
Volume | |
Open Interest | 257 |
The heavy selling pressure might have exhausted for LifeStance Health (LFST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SCOTTSDALE, Ariz., May 23, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will participate in the following upcoming investor conferences. UBS Healthcare Services Cape Cod SummitParticipants: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor RelationsDate: Tuesday, June 4, 2024Location: Chatham Bars Inn, Chatham, MANote: No presentation due to event for
SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 20,000,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $6.25 per share, pursuant to a shelf registration statement filed with the S